Polarity Protein SCRIB Interacts with SLC3A2 to Regulate Proliferation and Tamoxifen Resistance in ER+ Breast Cancer

Researchers showed an unexpected role for the cell polarity protein SCRIB as a tumor-promoter and a regulator of endocrine resistance in estrogen receptor (ER) -positive breast cancer cells.